← All stocks

Cytek Biosciences, Inc.

CTKB Net buying
CIK 0001831915 #2941 in the set updated 18 Sep 2026
Bought (120 mo)
$100.44M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$10.87M
$2.24M on a plan · $453.84K straight out of an exercise
Sold at will
$8.18M
53 of 75 sales
Net
+$89.57M
+$92.27M against sales at will

By person

19 insiders · 109 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RA CAPITAL MANAGEMENT, L.P. entity
Director
$100.15M (22)
+$100.15M
13,888,778
10.69%
$38.61M
+2,635%
Yan Ming
CHIEF TECHNOLOGY OFFICER
$5.38M (33)
−$5.38M
4,821,870
3.71%
$13.40M
−40.7%
Jiang Wenbin
PRESIDENT AND CEO
$4.67M (23)
−$4.67M
8,227,629
6.33%
$22.87M
+4.0%
Jeanmonod Patrik
CHIEF FINANCIAL OFFICER
$581.16K (18)
−$581.16K
97,465
0.0750%
$270.95K
+7.0%
Ball Jack
Director
$51.00K (1)
$235.04K (1) scheduled
−$184.04K
86,678
0.0667%
$240.96K
McCombe William D.
Chief Financial Officer
$97.30K (1)
+$97.30K
134,693
0.1036%
$374.45K
Dion Gisele
Director
$85.00K (1)
+$85.00K
5,000
0.0038%
$13.90K
Barnett Valerie
CHIEF LEGAL OFFICER
$32.30K (1)
+$32.30K
150,012
0.1154%
$417.03K
+1,771%
Poirson Allen
SVP BUS. AND CORP. DEV.
$25.50K (1)
+$25.50K
59,981
0.0461%
$166.75K
+50.8%
DENG FENG
Director
443,800
0.3414%
$1.23M
Holder Michael
Director
62,875
0.0484%
$174.79K
Imper Vera
Director
59,679
0.0459%
$165.91K
NEFF DEBORAH J
Director
59,679
0.0459%
$165.91K
Busque Philippe
SVP, GLOBAL SALES AND SERVICES
43,466
0.0334%
$120.84K
Chin Richard
Director
28,499
0.0219%
$79.23K
Williams Paul Christopher
CHIEF OPERATING OFFICER
16,473
0.0127%
$45.79K
HARDISON DON M
Director
15,706
0.0121%
$43.66K
Garland Jonathan Todd
Chief Commercial Officer
8,763
0.0067%
$24.36K
MUIR GLENN P
Director
3,086
0.0024%
$8.58K
Insider
Date
Role
Action
Shares
Price
Amount
Yan Ming
21 Feb 2023
Chief Technology Officer
Sold after exercise
20,000
$10.94
$218.80K
Ball Jack
14 Nov 2022
Director
Sold after exercise
16,000
$14.69
$235.04K

What was left out

Form 4 filings counted 272
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 20
Sales straight out of an exercise 2
Sales at will 53
Transactions with no price 0
Shares from compensation/vesting 22,121,719
Sales filed before the plan box existed 40
History held since 26 Jul 2021